Trial Profile
A retrospective study of COVID-19 in severe asthmatic patients receiving biological treatment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Nov 2022
Price :
$35
*
At a glance
- Drugs Mepolizumab (Primary) ; Omalizumab
- Indications COVID 2019 infections; Pneumonia
- Focus Therapeutic Use
- 02 Nov 2022 New trial record
- 01 Nov 2022 Results published in the Journal of Asthma